Keywords: Sanofi-Aventis, Genzyme, Plavix

Sanofi-Aventis CEO reasonably confident of doing deal for Genzyme, but in no hurry

Article | 16 September 2010

Chris Viehbacher, chief executive of French drug major Sanofi-Aventis, has made clear that he will pursue his takeover target US ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in